Revelol Sa 50mg Tablet
10 Tablet(s) in StripMRP ₹31.89
₹23.92
25% OFF
Made by
IPCA LABORATORIES
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Metoprolol(50.0 Mg) |
| Uses | High blood pressure, angina (chest pain), prevent heart attack and migraine |
| Therapy | Anti-hypertensive, anti-anginal |
| Side effects | Nausea, vomiting, dizziness, headache, low blood pressure |
Assurance
available
Regulated
Medical Description
Uses
Contraindications
- If you are allergic to metoprolol or other ingredients of Revelol Sa Tablet.
- If you have a heart condition such as heart block, uncontrolled heart failure.
- If you have asthma, Chronic Obstructive Pulmonary Disease (COPD) or lung condition.
- If you have low blood pressure, diabetes, renal or liver disease, a decreased heart rate.
- If you have an electrolyte imbalance, acid-base imbalance.
- If you are taking medication like verapamil, diltiazem, disopyramide (heart medicine).
Side effects
- Dizziness
- Headache
- Nausea
- Vomiting
- Stomach pain
- Tiredness
- A sudden drop in blood pressure when you stand from a seated or lying down position (orthodynamic hypotension)
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You experience an allergic reaction after taking the Revelol Sa Tablet.
- You have medical conditions such as diabetes, heart conditions, liver or kidney disease.
- You have respiratory conditions like asthma, obstructive lungs disease (COPD).
- You are pregnant, planning a pregnancy or are breastfeeding.
- You have a tumour of the adrenal gland tissue (Pheochromocytoma).
- You have an overactive thyroid (a condition when the thyroid gland produces too much of the thyroxine hormone).
- You are suffering from a type of skin disease psoriasis.
- You have circulation related problems in the toes, arm, legs or fingers.
- You are suffering from a type of chest pain (Prinzmetal’s angina).
- You recently had a heart attack, chest pain or heart surgery.
- Revelol Sa Tablet should not be used in children below 18 years of age.
Directions for Use
Storage and disposal
- Store Revelol Sa Tablets below 25°C. Protect it from light and moisture.
- Keep it out of the reach and sight of children and pets.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
Interactions
Interactions with other medicines
- Some medicines can affect the way the Revelol Sa works or this medicine itself may reduce the effectiveness of other medicines taken at the same time.
- Tell the doctor about all the medicines, supplements or herbals you are currently taking or might take to avoid possible interaction.
- Especially, if you are taking medicines to treat high blood pressure, heart failure, high/abnormal cholesterol levels, blood thinners, anti-infectives, anti-diabetics, anti-asthmatics, pain killers, immunomodulatory medicines or medicines for a brain-related disorder.
Frequently Asked Questions (FAQs)
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:REVELOL SA
Manufacturer Name:IPCA LABORATORIES
Address:<p>1. 142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra</p>
Country of Origin:India
Vendor Details
Fulfillment Information: Revelol Sa 50 MG Tablet (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Metoprolol film-coated tablets - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 18 July 2025]
- CDSCO [Internet]. Cdscoonline.gov.in. 2025 [cited 18 July 2025]
- METOPROLOL SUCCINATE- metoprolol succinate ER tablets tablet, film coated, extended release [Internet]. Dailymed.nlm.nih.gov. 2025 [cited 18 July 2025]
- Lactmed - Metoprolol [Internet]. Ncbi.nlm.nih.gov. 2025 [cited 18 July 2025]
- Metoprolol film-coated tablets - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2025 [cited 18 July 2025]
- U.S. Food and Drug Administration. Labeling information for Xarelto (Rivaroxaban).[cited 28 Feb 2025]
- Van der Meer FJ, de Maat MP, Rosendaal FR, et al. The role of the coagulation system in the pathogenesis of venous thrombosis. Thromb Haemost.[cited 28 Feb 2025]
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.



















